Basic Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Sep 1, 2004; 10(17): 2514-2518
Published online Sep 1, 2004. doi: 10.3748/wjg.v10.i17.2514
Figure 1
Figure 1 Effects of MP pretreatment on transepithelial electrophysiological characteristics. Comparison of potential difference (A) transepithelial ISC (B) and transepithelial resistance (C) in T84 cells with and without MP (15 mg/mL, 72 h) pretreatment. Values are mean ± SE; a (b)P < 0.01; b (a)P < 0.05; c (d)P < 0.001.
Figure 2
Figure 2 RT-PCR analyses of mRNA expressions of ZO-1 and ZO-2 in T84 cells. (A) RT-PCR results with products as expected of ZO-1 and ZO-2 found in control, MP pretreatment and ligustrazine pretreatment. Semi-quantitative analyses of ZO-1 (B) and ZO-2 (C) expressions in T84 cells without and with MP or ligustrazine pretreatment, which were shown in ratio of ZO-1 or ZO-2 to GAPDH (internal marker). Values are mean ± SE; aP and b (c)P < 0.05; c (d)P < 0.001.
Figure 3
Figure 3 MP-induced ISC in T84 cell lines. A: Representative ISC recordings in response to MP (10, 50, 100, 500, 1000 and 5000 mg/mL) added to the apical side. Arrowheads indicate the time of MP addition. B: The concentration-response curve for MP-induced responses. Different concentrations of MP were added to the apical side and each data was obtained from at least 3 individual experiments. Values are mean ± SE of maximal ISC increase.
Figure 4
Figure 4 Anion dependence of MP-induced ISC. A: Representative ISC recording with arrows indicating the time for apical addition of MP (500 mg/mL) and DPC (1 mmol/L). B: Summary of the effects of DPC (1 mmol/L, apical), glibenclamide (1 mmol/L, apical), bumetanide (100 mmol/L, basolateral), amiloride (10 mmol/L, apical) and DIDS (100 mmol/L, apical) on MP-induced ISC. Values are mean ± SE; bP < 0.01.
Figure 5
Figure 5 Anion dependence of ligustrazine-induced ISC. A: Representative ISC recording with arrows indicating the time for apical addition of ligustrazine (1 mmol/L) and glibemclamide (1 mmol/L). B: Summary of the effects of removal of extracellular Cl-, basolateral addition of bumetanide (100 mmol/L) and apical addition of DPC (1 mmol/L) on ligustrazine-induced ISC. Values are mean ± SE; dP, bP and fP < 0.001.